DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
129.55
+0.36 (0.28%)
Oct 27, 2025, 4:00 PM EDT - Market closed
DaVita Revenue
DaVita had revenue of $3.38B in the quarter ending June 30, 2025, with 6.05% growth. This brings the company's revenue in the last twelve months to $13.16B, up 5.09% year-over-year. In the year 2024, DaVita had annual revenue of $12.82B with 5.56% growth.
Revenue (ttm)
$13.16B
Revenue Growth
+5.09%
P/S Ratio
0.79
Revenue / Employee
$173,175
Employees
76,000
Market Cap
9.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.82B | 675.40M | 5.56% |
| Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
| Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
| Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
| Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
DVA News
- 7 days ago - DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives - PRNewsWire
- 14 days ago - DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call - PRNewsWire
- 2 months ago - DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care - PRNewsWire
- 2 months ago - Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows - Reuters
- 2 months ago - DaVita: Aggressive Buybacks Despite Rising Cost Of Debt - Seeking Alpha
- 2 months ago - DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - DaVita beats quarterly profit on steady demand for dialysis services - Reuters
- 2 months ago - DaVita Inc. 2nd Quarter 2025 Results - PRNewsWire